Recently, interferon gamma release assays (IGRAs) have become an important clinical tool for detecting latent tuberculosis. However, IGRA results may impede making a diagnosis. We herein present an interesting case of miliary tuberculosis with a nonspecific IGRA reaction due to hemophagocytosis.
A 64-year-old man with advanced chronic kidney disease due to nephrosclerosis and ischemic heart disease was admitted to our hospital with an intermittent high-grade fever lasting for one week. The plan was to initiate hemodialysis therapy, and the patient underwent surgery for internal shunt ostomy in the left upper arm two months prior to admission. He was given neither steroids nor other immunosuppressants. On admission, he was free from respiratory symptoms, such as a productive cough. His laboratory data and radiological findings were evaluated. The clinical laboratory data obtained on admission confirmed a high alkaline phosphatase level (above 2,000 IU/mL) and a decreased hemoglobin (Hgb) level (below 10.0 g/dL). The serum C-reactive protein and procalcitonin levels were elevated, indicating an inflammatory reaction. The soluble interleukin-2 receptor (sIL-2R) level was elevated to 18,986 U/mL. Both anti-HIV and anti-human T-cell leukemia virus (HTLV) antibodies were negative. He had no history of hematological diseases. Chest roentogenography performed on admission showed no abnormalities, except cardiomegaly ( Figure A) .
We initially suspected a bloodstream infection, such as infectious endocarditis, and thus performed blood cultures and serological surveillance. However, these microbiological inspections yielded no useful data. On the other hand, chest computed tomography revealed slight density changes in both lung fields ( Figure B) ; however, the patient had no respiratory symptoms. Although we recognized a slight density elevation in the pulmonary alveolar field, radiologists in our hospital did not mention these findings, and miliary tuberculosis was not suspected. The detection of a column appearance depends on the type of monitor used. We attempted to obtain respiratory samples to detect pulmonary infections, including tuberculosis. However, due to the lack of sputum production, we were unable to obtain respiratory samples. The interferon gamma release assay (IGRA, QuantiFERON-TB TM Gold In-tube (QFT-3G)) results showed values for both negative and positive controls as well as the patient's samples exceeding 8.01 IU/mL. According to previous guidelines for using IGRAs (1), our patient's results were invalid due to the nonspecific reaction of the negative control (a positive reaction in the negative control).
Despite conducting further studies, a final diagnosis was not reached, and the patient's condition deteriorated. Hemo- 
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dialysis was started on the 8th hospital day to treat the advanced chronic kidney disease; however, uncontrollable hemodynamics necessitated transfer to the intensive care unit (ICU) on the 10th hospital day.
In the ICU, we administered continuous renal replacement therapy to control the patient's hemodynamic state. However, on the 13th hospital day, the laboratory data showed ongoing disseminated intravascular coagulation and multiple organ failure. We added anticoagulant agents and catecholamines to the treatment regimen; however, his condition deteriorated further. On the 32nd hospital day, acid-fast bacilli (AFB) from a blood culture sample obtained on the 9th hospital day were detected using the BD BACTEC TM FX system with BD BACTEC TM Myco/F Lytic Culture Vials (Becton, Dickinson and Company, Sparks, MD, USA). The AFB were identified to be Mycobacterium tuberculosis complex using a Capilia TB TM test (BD, Tokyo, Japan). On the other hand, a bone marrow biopsy specimen obtained on the 28th hospital day revealed typical caseation necrosis and hemophagocytosis and also stained positive for AFB. We ultimately diagnosed the patient with miliary tuberculosis.
The final diagnosis prompted the immediate administration of antituberculous agents, including isoniazid, rifampicin, ethambutol and levofloxacin; however, the patient died on the 38th hospital day of rapidly progressive multiple organ failure.
Discussion
IGRAs are diagnostic medical tools used to detect latent tuberculosis. IGRAs depend on the interferon-γ released from T-lymphocytes when stimulated by specific antigens derived from the M. tuberculosis complex, ESAT-6 and CFP-10 (2, 3). Two IGRAs are currently available for the diagnosis of tuberculosis: QFT-3G, a form of the enzymelinked immunosorbent assay (ELISA, licensed in the USA, Europe and Japan); and T-SPOT.TB TM , a form of the enzyme-linked immunospot assay (ELISPOT, licensed in Europe and Japan). Several previous reports have described the sensitivity of T-SPOT.TB TM as being higher than that of QFT-3G (4). In particular, in patients with HIV infection, the T-SPOT.TB TM has been reported to have improved sensitivity for the detection of latent tuberculosis compared to the QuantiFERON-TB TM Gold (QFT-2G) (5), the previous generation QFT. It is also noteworthy that there are fewer indeterminant results with T-SPOT.TB TM than with QFT (6). The QFT-3G represents an improvement in that another specific synthetic protein derived from M. tuberculosis, TB7.7 (Rv2654) (7) , has been added, and the stimulation of peripheral blood lymphocytes is possible beginning immediately after blood collection. Although the sensitivity of QFT-3G is improved compared to that of QFT-2G, a previous report described the sensitivity of T-SPOT.TB TM as being higher than that of both QFT-2G and -3G (4). Currently, IGRAs are regarded as being good diagnostic tools for detecting activated or latent tuberculosis, not only by non-respiratory physicians, but also by pulmonologists. Indeed, IGRAs have become essential for diagnosing tuberculosis in this decade. However, it is also important to assess indeterminant results.
Indeterminate results show two patterns: an insignificant result typical of a sample assay (true indeterminate results), and an abnormal response in the control assay (rather than "no judgment"). Formerly, indeterminate results were interrupted considering the overall risk of tuberculosis. However, "no judgment" has been interpreted as the inability to judge the result due to the presence of a latent immunocompromised state. We suggest that rather than making a conclusion of "no judgment," these results are important for diagnosing tuberculosis.
False control assay responses are divided into positive and negative findings. Positivity of a negative control is caused by a high level of IFN-γ in the sample serum. In patients with miliary tuberculosis, the pathological specimens show hemophagocytosis in the bone marrow. Previous reports have shown IFN-γ production to be accelerated in the hemophagocytic reaction (8) (9) (10) . On the other hand, the baseline concentration of IFN-γ is high in patients with autoimmune diseases, such as systemic lupus erythematosus (11) (12) (13) and rheumatoid arthritis (13, 14) . Moreover, some viral infections cause a high production of IFN-γ (15) (16) (17) . Negative changes in a positive control are caused by individual background factors, such as an immunocompromised status, including acquired immunodeficiency syndrome or immunosuppressant intake. The level of anti-IFN-γ autoantibodies, as reported in severe infectious diseases, including sepsis caused by opportunistic pathogens (18) or disseminated nontuberculous mycobacterium infection (19, 20) , is also high in this situation.
In the present case, the "no judgment" IGRA result may have ended further investigations of tuberculosis, despite the presence of several clinical signs of tuberculosis. It appears that the present patient had miliary tuberculosis accompanied by hemophagocytosis. Therefore, we speculate that a high level of secretion of inflammatory cytokines, including IFN-γ, had occurred and that the IGRA results accounted for the control being negative for inappropriate secretion of cytokines. We recommend that respiratory physicians sufficiently assess IGRA results, including both indeterminate findings and the "no judgment" outcome. Miliary tuberculosis is usually associated with several abnormalities of the host immune response, including a high production of IFNγ. In both patients with miliary tuberculosis and an immunocompromised state, the IGRA result of "no judgment" should be seen as the default. Beyond IGRA, further evaluations are required in patients suspected to have miliary tuberculosis.
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